bioinformatics is harder than biostatistics in finding a pharma job. biostatistics is for analyzing clinical trial, which is critical to pharma. bioinformatics is for upstream research, good to have, but not critical
【在 d***3 的大作中提到】 : Which level are you talking about then?
l*e
18 楼
是不是做抗体的都特别好进?
【在 h*****n 的大作中提到】 : 生化?遗传?癌症?糖尿病?神经退化疾病?
d*3
19 楼
Are you talking about a small biotech? To be a team leader, experience is usually more important than CNS papers. If you are already an AP, that may be evaluated at a different level.
【在 g********0 的大作中提到】 : team leader
d*3
20 楼
My personal view 生化? Too many people in the pool unless you are specialized in areas like enzymology. There may not be a lot opportunities in those special areas, but you will be very competitive if there is an opening. However, if you are very strong, there are always openings in this area since it is more technical driven. 遗传? Is it still hot? Maybe not. However, specialized in personalized medicine may have a good future. 癌症? A lot of opportunities, big and small. Because the hurdle is relative low, most if not all big pharms will keep and expand it. 糖尿病? A huge market with very high hurdle. Most big pharms will try to keep it with reduced sizes. However, small biotechs may have good opportunities in the next ten years. Big pharms will compete for good external assets while reducing internal cost. 神经退化疾病? A rapid growing area. Not bad to enter now.